Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.95 USD
Change Today 0.00 / 0.00%
Volume 0.0
EXEL On Other Exchanges
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael M. Morrissey Ph.D.

Chief Executive Officer, President and Director,Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael M. Morrissey, Ph.D. has been the Chief Executive Officer and President at Exelixis, Inc., since July 2010. Dr. Morrissey served as the President of Research and Development at Exelixis Inc., since January 4, 2007. Dr. Morrissey served as an Executive Vice President of Discovery of Exelixis Inc., from January 2006 to December 2006 and its Senior Vice President of Discovery Research from January 2003 to December 2005. Dr. Morrissey served as Vice President ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

Chief Executive Officer, President and Director


Harvard University
Concordia University, Wisconsin

Other Affiliations*

Annual Compensation*

Total Annual Compensation$755,192

Stock Options*

All Other Compensation$7,800
Exercisable Options1,891,750
Unexercisable Options755,250
Total Number of Options4,012,000

Total Compensation*

Total Annual Cash Compensation$762,992
Total Short Term Compensation$755,192
Other Long Term Compensation$7,800
Total Calculated Compensation$2,141,792
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $5.95 USD 0.00


Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer and President
Ariad Pharmaceuticals Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at